CVS Caremark (CVS) Tops Q3 EPS by 3c; Adjusts FY11 EPS Below Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $79.96 -12.53%
Financial Fact:
Income before income tax provision: 2.46B
Today's EPS Names:
KTB, CABO, FDUS, More
Financial Fact:
Income before income tax provision: 2.46B
Today's EPS Names:
KTB, CABO, FDUS, More
Join SI Premium – FREE
CVS Caremark (NYSE: CVS) reported Q3 EPS of $0.70, $0.03 better than the analyst estimate of $0.67. Revenue for the quarter came in at $26.7 billion versus the consensus estimate of $26.76 billion.
CVS Caremark sees FY2011 EPS of $2.57-$2.61, versus the consensus of $2.78.
CVS Caremark sees FY2011 EPS of $2.57-$2.61, versus the consensus of $2.78.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ardent Health Partners, Inc. (ARDT) Tops Q3 EPS by 8c; offers guidance
- BillionToOne, Inc. (BLLN) Tops Q3 EPS by 23c; Offers Guidance
- Myriad Genetics (MYGN) Tops Q3 EPS by 9c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
